Lee Medical Case Review, LLC

Lee Medical Case Review, LLC, a woman-owned, veteran-owned, and service-disabled veteran-owned sole proprietorship based in Silver Spring, Maryland, provides medical case review and expert witness services to the federal government exclusively as a prime contractor under two single-award blanket purchase agreements with the Department of Health and Human Services Health Resources and Services Administration (HRSA). The vendor competes without set-aside designation on its primary BPA vehicle but receives task orders carrying Total Small Business set-aside markings on a recurring basis.

Lee Medical Case Review holds a $7.5 million single-award BPA (75R60222A00023) with HRSA running through June 2027, established June 2, 2022, for medical case review services supporting the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP). The vendor also holds a secondary smaller BPA (75R60220A00015) under the same programs. Task orders issued under these vehicles require the vendor to analyze claimant medical records, evaluate evidence, and provide expert recommendations to support HRSA's determination of vaccine injury compensation eligibility. Individual call orders typically range from $12,500 to $25,000 with performance periods of six to eighteen months. Recent representative task orders include a $50,000 VICP case review call awarded September 3, 2026, with completion August 2, 2027; a $25,000 CICP case evaluation call awarded June 12, 2026, under Total Small Business set-aside with completion May 11, 2027; and a $25,000 VICP case review call awarded August 12, 2026, with completion July 11, 2027. Performance occurs at HRSA headquarters in Silver Spring and Rockville, Maryland.

The vendor operates with complete customer concentration—100% of awards fund HRSA's vaccine injury and countermeasures injury compensation programs across 42 awards totaling $8.6 million in combined potential value. Lee Medical Case Review has received 25 task orders under the primary BPA (75R60222A00023) totaling $608 thousand and 15 task orders under the secondary BPA totaling $245 thousand. Activity has declined modestly year over year, from eight awards in 2022 to four in 2026 year-to-date. Four awards carrying combined potential value of $125 thousand face ultimate completion within the next twenty-four months, representing recompete exposure. The vendor holds no subcontracts and operates exclusively within federal medical case review and expert witness services under PSC code for support-professional expert witness services.